Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2003 Jun;53(491):480–487.

A systematic review and meta-analysis of treatments for impetigo.

Ajay George 1, Greg Rubin 1
PMCID: PMC1314624  PMID: 12939895

Abstract

BACKGROUND: Impetigo is a common clinical problem seen in general practice. Uncertainty exists as to the most effective treatment, or indeed if treatment is necessary. AIM: To determine the most effective treatment for impetigo in a systemically well patient. DESIGN OF STUDY: Systematic review and meta-analysis. METHOD: Databases were searched for relevant studies. The Cochrane highly sensitive randomised controlled trial (RCT) search string was employed and combined with the word 'impetigo' as the MeSH term and keyword. The bibliographies of relevant articles were searched for additional references. RCTs that were either double- or observer-blind, and involved systemically well patients of any age in either primary or secondary care settings, were included. Studies that selected patients on the basis of skin swab results were excluded, as were studies that were not in English. Cure or improvement of impetigo reported at seven to 14 days from start of treatment was the primary outcome measure. Meta-analysis was performed on homogeneous studies. RESULTS: Three hundred and fifty-nine studies were identified, of which 16 met the inclusion criteria. Meta-analysis demonstrated that topical antibiotics are more effective than placebo (odds ratio [OR] = 2.69, 95% confidence interval [CI] = 1.49 to 4.86). There is weak evidence for the superiority of topical antibiotics over some oral antibiotics, such as erythromycin (OR = 0.48, 95% CI = 0.23 to 1.00). There is no significant difference between the effects of mupirocin and fusidic acid (OR = 1.76, 95% CI = 0.77 to 4.03). CONCLUSION: This review found limited high-quality evidence to inform the treatment of impetigo. From that which is available, we would recommend the use of a topical antibiotic for a period of seven days in a systemically well patient with limited disease. Further research is needed on the role of flucloxacillin and non-antibiotic treatments for impetigo.

Full Text

The Full Text of this article is available as a PDF (98.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltimore R. S. Treatment of impetigo: a review. Pediatr Infect Dis. 1985 Sep-Oct;4(5):597–601. doi: 10.1097/00006454-198509000-00061. [DOI] [PubMed] [Google Scholar]
  2. Bareggi S. R., Pirola R., De Benedittis G. Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia. Eur J Clin Pharmacol. 1998 May;54(3):231–235. doi: 10.1007/s002280050451. [DOI] [PubMed] [Google Scholar]
  3. Bass J. W., Chan D. S., Creamer K. M., Thompson M. W., Malone F. J., Becker T. M., Marks S. N. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J. 1997 Jul;16(7):708–710. doi: 10.1097/00006454-199707000-00013. [DOI] [PubMed] [Google Scholar]
  4. Bethune L. Towards evidence based emergency medicine: best BETS from the Manchester Royal Infirmary. Radiography for fish bones in the throat. J Accid Emerg Med. 1999 Sep;16(5):362–363. doi: 10.1136/emj.16.5.362-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Britton J. W., Fajardo J. E., Krafte-Jacobs B. Comparison of mupirocin and erythromycin in the treatment of impetigo. J Pediatr. 1990 Nov;117(5):827–829. doi: 10.1016/s0022-3476(05)83352-9. [DOI] [PubMed] [Google Scholar]
  6. Carruthers R. Prescribing antibiotics for impetigo. Drugs. 1988 Sep;36(3):364–369. doi: 10.2165/00003495-198836030-00006. [DOI] [PubMed] [Google Scholar]
  7. Cassels-Brown G. A comparative study of Fucidin Ointment and Cicatrin Cream in the treatment of impetigo. Br J Clin Pract. 1981 Apr;35(4):153–155. [PubMed] [Google Scholar]
  8. Dagan R., Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 1992 Feb;36(2):287–290. doi: 10.1128/aac.36.2.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dagan R. Impetigo in childhood: changing epidemiology and new treatments. Pediatr Ann. 1993 Apr;22(4):235–240. doi: 10.3928/0090-4481-19930401-07. [DOI] [PubMed] [Google Scholar]
  10. Darmstadt G. L., Lane A. T. Impetigo: an overview. Pediatr Dermatol. 1994 Dec;11(4):293–303. doi: 10.1111/j.1525-1470.1994.tb00092.x. [DOI] [PubMed] [Google Scholar]
  11. Demidovich C. W., Wittler R. R., Ruff M. E., Bass J. W., Browning W. C. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child. 1990 Dec;144(12):1313–1315. doi: 10.1001/archpedi.1990.02150360037015. [DOI] [PubMed] [Google Scholar]
  12. Eells L. D., Mertz P. M., Piovanetti Y., Pekoe G. M., Eaglstein W. H. Topical antibiotic treatment of impetigo with mupirocin. Arch Dermatol. 1986 Nov;122(11):1273–1276. [PubMed] [Google Scholar]
  13. Feder H. M., Jr, Abrahamian L. M., Grant-Kels J. M. Is penicillin still the drug of choice for non-bullous impetigo? Lancet. 1991 Sep 28;338(8770):803–805. doi: 10.1016/0140-6736(91)90679-j. [DOI] [PubMed] [Google Scholar]
  14. Gilbert M. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol. 1989 Jun;20(6):1083–1087. doi: 10.1016/s0190-9622(89)70137-7. [DOI] [PubMed] [Google Scholar]
  15. Hart C. A. Antibiotic resistance: an increasing problem?. It always has been, but there are things we can do. BMJ. 1998 Apr 25;316(7140):1255–1256. doi: 10.1136/bmj.316.7140.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  17. Jaffé G. V., Grimshaw J. J. A clinical trial of hydrocortisone/potassium hydroxyquinoline sulphate ('Quinocort') in the treatment of infected eczema and impetigo in general practice. Pharmatherapeutica. 1986;4(10):628–636. [PubMed] [Google Scholar]
  18. Koning Sander, van Suijlekom-Smit Lisette W. A., Nouwen Jan L., Verduin Cees M., Bernsen Roos M. D., Oranje Arnold P., Thomas Siep, van der Wouden Johannes C. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ. 2002 Jan 26;324(7331):203–206. doi: 10.1136/bmj.324.7331.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Koranyi K. I., Burech D. L., Haynes R. E. Evaluation of bacitracin ointment in the treatment of impetigo. Ohio State Med J. 1976 Jun;72(6):368–370. [PubMed] [Google Scholar]
  20. Moher D., Pham B., Klassen T. P., Schulz K. F., Berlin J. A., Jadad A. R., Liberati A. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000 Sep;53(9):964–972. doi: 10.1016/s0895-4356(00)00188-8. [DOI] [PubMed] [Google Scholar]
  21. Morley P. A., Munot L. D. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis. Curr Med Res Opin. 1988;11(2):142–148. doi: 10.1185/03007998809110457. [DOI] [PubMed] [Google Scholar]
  22. Nolting S., Strauss W. B. Treatment of impetigo and ecthyma. A comparison of sulconazole with miconazole. Int J Dermatol. 1988 Dec;27(10):716–719. doi: 10.1111/j.1365-4362.1988.tb01273.x. [DOI] [PubMed] [Google Scholar]
  23. Ruby R. J., Nelson J. D. The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo. Pediatrics. 1973 Dec;52(6):854–859. [PubMed] [Google Scholar]
  24. Sharquie K. E., al-Turfi I. A., al-Salloum S. M. The antibacterial activity of tea in vitro and in vivo (in patients with impetigo contagiosa). J Dermatol. 2000 Nov;27(11):706–710. doi: 10.1111/j.1346-8138.2000.tb02263.x. [DOI] [PubMed] [Google Scholar]
  25. Stringel G., Bawdon R., Savrich M., Guertin L., Horton J. Topical and systemic antibiotics in the prevention of wound infection. J Pediatr Surg. 1989 Oct;24(10):1003–1006. doi: 10.1016/s0022-3468(89)80202-7. [DOI] [PubMed] [Google Scholar]
  26. Vainer G., Torbensen E. Behandling af impetigo i almen praksis. En sammenligning mellem tre lokalantibiotika. Ugeskr Laeger. 1986 May 12;148(20):1202–1206. [PubMed] [Google Scholar]
  27. White D. G., Collins P. O., Rowsell R. B. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate. J Infect. 1989 May;18(3):221–229. doi: 10.1016/s0163-4453(89)80058-1. [DOI] [PubMed] [Google Scholar]
  28. Zaynoun S. T., Matta M. T., Uwayda M. M., Kurban A. K. Topical antibiotics in pyodermas. Br J Dermatol. 1974 Mar;90(3):331–334. doi: 10.1111/j.1365-2133.1974.tb06411.x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES